More importantly, with treatment of trastuzumab, tumour cells that infected with Lv‐SNHG14 grew faster than controls (Group III vs Group IV), suggesting that SNHG14 repressed the cell cytotoxicity induced by treatment with trastuzumab in vivo (Figure 6B). The gene discussed is SNHG14; the disease is neoplasm.